Polpharma is the largest Polish manufacturer of active pharmaceutical ingredients (APIs), or active ingredients for the production of finished drug forms. They are available in more than 60 countries, including the largest markets: USA, TOP5EU, in Japan, Korea, Brazil, China and many others.
In 2021, Polpharma launched a comprehensive investment program for further development of active substances, which includes, among other things, the construction of a plant for the production of highly potent APIs. One of the milestones of the adopted strategy is the commissioning of a new kilo-scale development and production laboratory (“Kilo Lab”). Filled with the latest technology, the facility enables the production of the most advanced substances in Poland.